1. Academic Validation
  2. Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model

Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model

  • Sci Rep. 2024 Apr 8;14(1):8241. doi: 10.1038/s41598-024-57659-x.
Pedro H L Viana 1 Csaba A Schvarcz 1 2 Lea O Danics 1 Balázs Besztercei 1 Kenan Aloss 1 Syeda M Z Bokhari 1 Nino Giunashvili 1 Dániel Bócsi 1 Zoltán Koós 1 Zoltán Benyó 1 2 Péter Hamar 3
Affiliations

Affiliations

  • 1 Institute of Translational Medicine, Semmelweis University, Tűzoltó Utca 37-47, Budapest, 1094, Hungary.
  • 2 HUN-REN-SU Cerebrovascular and Neurocognitive Diseases Research Group, Tűzoltó Utca 37-47, Budapest, 1094, Hungary.
  • 3 Institute of Translational Medicine, Semmelweis University, Tűzoltó Utca 37-47, Budapest, 1094, Hungary. hamar.peter@semmelweis.hu.
Abstract

Female breast Cancer is the most diagnosed Cancer worldwide. Triple negative breast Cancer (TNBC) is the most aggressive type and there is no existing endocrine or targeted therapy. Modulated electro-hyperthermia (mEHT) is a non-invasive complementary Cancer therapy using an electromagnetic field generated by amplitude modulated 13.56 MHz frequency that induces tumor cell destruction. However, we have demonstrated a strong induction of the heat shock response (HSR) by mEHT, which can result in thermotolerance. We hypothesized that inhibition of the heat shock factor 1 (HSF1) can synergize with mEHT and enhance tumor cell-killing. Thus, we either knocked down the HSF1 gene with a CRISPR/Cas9 lentiviral construct or inhibited HSF1 with a specific small molecule inhibitor: KRIBB11 in vivo. Wild type or HSF1-knockdown 4T1 TNBC cells were inoculated into the mammary gland's fat pad of BALB/c mice. Four mEHT treatments were performed every second day and the tumor growth was followed by ultrasound and caliper. KRIBB11 was administrated intraperitoneally at 50 mg/kg daily for 8 days. HSF1 and HSP70 expression were assessed. HSF1 knockdown sensitized transduced Cancer cells to mEHT and reduced tumor growth. HSF1 mRNA expression was significantly reduced in the KO group when compared to the empty vector group, and consequently mEHT-induced HSP70 mRNA upregulation diminished in the KO group. Immunohistochemistry (IHC) confirmed the inhibition of HSP70 upregulation in mEHT HSF1-KO group. Demonstrating the translational potential of HSF1 inhibition, combined therapy of mEHT with KRIBB11 significantly reduced tumor mass compared to either monotherapy. Inhibition of HSP70 upregulation by mEHT was also supported by qPCR and IHC. In conclusion, we suggest that mEHT-therapy combined with HSF1 inhibition can be a possible new strategy of TNBC treatment with great translational potential.

Keywords

HSF1; Heat shock response; Hsp70; Modulated electro-hyperthermia; Triple-negative breast cancer.

Figures
Products